BioSpace News Archive

Omega Therapeutics is harnessing the power of epigenetics in an unprecedented way and engineering programmable epigenetic mRNA therapeutics to transform medicine in the service of patients.

Recently, antimicrobial resistance has re-emerged in the public limelight as an increasingly severe global health problem.

Lunit announced its presentation of two abstracts featuring its AI-based immunotherapy response predictor at the 2022 United States and Canadian Academy of Pathology Annual Meeting, held in a hybrid, online-offline format on March 19-24.

The kidney transplant market has been projected to grow at a noteworthy speed in the foreseeable years.

The bioprocess containers market has been estimated to expand at a significant speed in the foreseeable years.

Athira Pharma, Inc. announced that study overview and baseline data from ACT-AD, a fully enrolled Phase 2 clinical trial of Athira’s lead development candidate, fosgonimeton in study participants with mild-to-moderate Alzheimer’s disease, were presented in an oral presentation at the International Conference on Alzheimer’s and Parkinson’s Disease and Related Neurological Diseases taking place in Barcelona, Spain, and virtually from March 15-20, 2022.

GenScript Biotech, the world’s leading biotech company, announces its annual results as of December 31, 2021.

The digital pathology market has been projected to grow at a significant speed in the foreseeable years.

The animal growth promoters and performance enhancer market has been anticipated to grow at a noteworthy speed in the years to come.

Albany NY, United States: The growing population worldwide who need wheeled mobility devices is a key underpinning to the expansion of the wheelchairs market.